Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
How decades of clinical trials have transformed breast cancer radiotherapy
After leading numerous practice-changing trials, Professor John Yarnold received a prestigious award at the 2021 ESTRO Congress. For Breast Cancer Awareness Month, Diana Cano looks back at the huge impact he has had in the field of breast cancer radiotherapy.
ICR research showcased in world-first exhibition exploring cutting-edge cancer research
A new world-first exhibition by the Science Museum Group titled Cancer Revolution: Science, innovation and hope features a series of pioneering research projects being carried out at The Institute of Cancer Research, London.
Targeted prostate cancer screening could benefit men with inherited cancer syndrome
Men who inherit an increased risk of cancer through ‘Lynch syndrome’ could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer, researchers believe.
ICR ranked as one of world’s top research institutes for influence and commercial impact
The Institute of Cancer Research is one of the top-ranked higher education institutions in the world for academic influence and commercial impact, according to an international assessment.
ICR Discovery Club returns in-person, looks to the future of treating children with cancer
Members of the Discovery Club reunited at the Royal Society in London for an intimate evening with some of our leading childhood cancer scientists.
Researchers find immune system link with rare ovarian cancer that could guide future treatment
Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found.
-being-attacked-by-two-cytotoxic-t-cells-(red)-547x410.tmb-hbmobile.png?Culture=en&sfvrsn=8f59440b_2 "Immunotherapy - Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red) 547x410")
ESMO 2021: Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers
An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests.
.jpg?sfvrsn=2f49a1c2_2 "HRH visit plaque unveiling (high res)")
The Princess Royal officially opens pioneering centre for 'Darwinian' cancer drug discovery
Her Royal Highness The Princess Royal has officially opened the Centre for Cancer Drug Discovery and toured the centre to learn more about its work to overcome cancer’s ability to evolve and become resistant to treatment.
'Gut bugs' can drive prostate cancer growth and treatment resistance
Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds.
Scientists use AI to identify new drug combination for children with incurable brain cancer
Scientists have used artificial intelligence-enhanced tools to successfully propose a new combination of drugs for use against an incurable childhood brain cancer.
ESMO 2021: Drug combination shows promise in treatment-resistant advanced ovarian cancer
A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients.
ESMO 2021: Abiraterone keeps men with prostate cancer at risk of spreading alive for longer
Giving the drug abiraterone alongside standard hormone therapy helps men with high-risk prostate cancer, that has not spread elsewhere in the body, live longer.